Pathogenesis and vascular integrity of breast cancer brain metastasis

Weixin Lu, Corazon D. Bucana, Alan J. Schroit

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Dogma dictates that brain metastasis originate from the proliferation of extravasated tumor cells and that the blood-brain barrier (BBB) prevents the delivery of chemotherapeutic drugs to the tumors. The purpose of this study was to clarify the relationship between tumor localization and progression and the involvement of BBB function in a murine model of breast cancer brain metastasis. Green fluorescent protein expressing MDA-MB435 breast cancer cells were injected into the left ventricle of nude mice. At various time points, the entire vasculature was labeled with rhodamine-conjugated albumin. The tumors and vasculature were then imaged by laser-scanning confocal and stereo fluorescence microscopy. About 75% of the cells that reached the brain extravasated and grew perivascularly. Twenty five percent of the cells, however, proliferated within the vasculature and ultimately led to thrombosis-like infarction of the brain parenchyma. The tumorigenic "embolus" served as a sustained release source of tumor cells to downstream sites. Continuing intravascular tumor expansion led to disruption of the BBB and to overflow of cells that progressed along the vessels perivascularly to distant sites that regained protection of the BBB. Breast cancer brain metastases involve both extravascular and intravascular growth of tumor cells. These distinct pathways contribute to different pathological phenotypes that generate a heterogeneous BBB that facilitates or inhibits the delivery of chemotherapeutic drugs to the tumor.

Original languageEnglish (US)
Pages (from-to)1023-1026
Number of pages4
JournalInternational Journal of Cancer
Volume120
Issue number5
DOIs
StatePublished - Mar 1 2007

Fingerprint

Brain Neoplasms
Blood Vessels
Breast Neoplasms
Neoplasm Metastasis
Blood-Brain Barrier
Neoplasms
Brain Infarction
Rhodamines
Brain
Green Fluorescent Proteins
Embolism
Fluorescence Microscopy
Nude Mice
Pharmaceutical Preparations
Heart Ventricles
Albumins
Lasers
Thrombosis
Phenotype
Growth

Keywords

  • Brain metastasis
  • Breast cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Pathogenesis and vascular integrity of breast cancer brain metastasis. / Lu, Weixin; Bucana, Corazon D.; Schroit, Alan J.

In: International Journal of Cancer, Vol. 120, No. 5, 01.03.2007, p. 1023-1026.

Research output: Contribution to journalArticle

Lu, Weixin ; Bucana, Corazon D. ; Schroit, Alan J. / Pathogenesis and vascular integrity of breast cancer brain metastasis. In: International Journal of Cancer. 2007 ; Vol. 120, No. 5. pp. 1023-1026.
@article{3bc2328f44a049aaa885d87c909d9db1,
title = "Pathogenesis and vascular integrity of breast cancer brain metastasis",
abstract = "Dogma dictates that brain metastasis originate from the proliferation of extravasated tumor cells and that the blood-brain barrier (BBB) prevents the delivery of chemotherapeutic drugs to the tumors. The purpose of this study was to clarify the relationship between tumor localization and progression and the involvement of BBB function in a murine model of breast cancer brain metastasis. Green fluorescent protein expressing MDA-MB435 breast cancer cells were injected into the left ventricle of nude mice. At various time points, the entire vasculature was labeled with rhodamine-conjugated albumin. The tumors and vasculature were then imaged by laser-scanning confocal and stereo fluorescence microscopy. About 75{\%} of the cells that reached the brain extravasated and grew perivascularly. Twenty five percent of the cells, however, proliferated within the vasculature and ultimately led to thrombosis-like infarction of the brain parenchyma. The tumorigenic {"}embolus{"} served as a sustained release source of tumor cells to downstream sites. Continuing intravascular tumor expansion led to disruption of the BBB and to overflow of cells that progressed along the vessels perivascularly to distant sites that regained protection of the BBB. Breast cancer brain metastases involve both extravascular and intravascular growth of tumor cells. These distinct pathways contribute to different pathological phenotypes that generate a heterogeneous BBB that facilitates or inhibits the delivery of chemotherapeutic drugs to the tumor.",
keywords = "Brain metastasis, Breast cancer",
author = "Weixin Lu and Bucana, {Corazon D.} and Schroit, {Alan J.}",
year = "2007",
month = "3",
day = "1",
doi = "10.1002/ijc.22388",
language = "English (US)",
volume = "120",
pages = "1023--1026",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Pathogenesis and vascular integrity of breast cancer brain metastasis

AU - Lu, Weixin

AU - Bucana, Corazon D.

AU - Schroit, Alan J.

PY - 2007/3/1

Y1 - 2007/3/1

N2 - Dogma dictates that brain metastasis originate from the proliferation of extravasated tumor cells and that the blood-brain barrier (BBB) prevents the delivery of chemotherapeutic drugs to the tumors. The purpose of this study was to clarify the relationship between tumor localization and progression and the involvement of BBB function in a murine model of breast cancer brain metastasis. Green fluorescent protein expressing MDA-MB435 breast cancer cells were injected into the left ventricle of nude mice. At various time points, the entire vasculature was labeled with rhodamine-conjugated albumin. The tumors and vasculature were then imaged by laser-scanning confocal and stereo fluorescence microscopy. About 75% of the cells that reached the brain extravasated and grew perivascularly. Twenty five percent of the cells, however, proliferated within the vasculature and ultimately led to thrombosis-like infarction of the brain parenchyma. The tumorigenic "embolus" served as a sustained release source of tumor cells to downstream sites. Continuing intravascular tumor expansion led to disruption of the BBB and to overflow of cells that progressed along the vessels perivascularly to distant sites that regained protection of the BBB. Breast cancer brain metastases involve both extravascular and intravascular growth of tumor cells. These distinct pathways contribute to different pathological phenotypes that generate a heterogeneous BBB that facilitates or inhibits the delivery of chemotherapeutic drugs to the tumor.

AB - Dogma dictates that brain metastasis originate from the proliferation of extravasated tumor cells and that the blood-brain barrier (BBB) prevents the delivery of chemotherapeutic drugs to the tumors. The purpose of this study was to clarify the relationship between tumor localization and progression and the involvement of BBB function in a murine model of breast cancer brain metastasis. Green fluorescent protein expressing MDA-MB435 breast cancer cells were injected into the left ventricle of nude mice. At various time points, the entire vasculature was labeled with rhodamine-conjugated albumin. The tumors and vasculature were then imaged by laser-scanning confocal and stereo fluorescence microscopy. About 75% of the cells that reached the brain extravasated and grew perivascularly. Twenty five percent of the cells, however, proliferated within the vasculature and ultimately led to thrombosis-like infarction of the brain parenchyma. The tumorigenic "embolus" served as a sustained release source of tumor cells to downstream sites. Continuing intravascular tumor expansion led to disruption of the BBB and to overflow of cells that progressed along the vessels perivascularly to distant sites that regained protection of the BBB. Breast cancer brain metastases involve both extravascular and intravascular growth of tumor cells. These distinct pathways contribute to different pathological phenotypes that generate a heterogeneous BBB that facilitates or inhibits the delivery of chemotherapeutic drugs to the tumor.

KW - Brain metastasis

KW - Breast cancer

UR - http://www.scopus.com/inward/record.url?scp=33846820253&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846820253&partnerID=8YFLogxK

U2 - 10.1002/ijc.22388

DO - 10.1002/ijc.22388

M3 - Article

C2 - 17187362

AN - SCOPUS:33846820253

VL - 120

SP - 1023

EP - 1026

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 5

ER -